Correlation Between Nu Med and Cannabis Suisse

Can any of the company-specific risk be diversified away by investing in both Nu Med and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nu Med and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nu Med Plus and Cannabis Suisse Corp, you can compare the effects of market volatilities on Nu Med and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nu Med with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nu Med and Cannabis Suisse.

Diversification Opportunities for Nu Med and Cannabis Suisse

-0.34

Correlation Coefficient

Nu Med  Cannabis Suisse

Very good diversification

The 3 months correlation between NUMD and Cannabis is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Nu Med Plus and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Nu Med is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nu Med Plus are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Nu Med i.e., Nu Med and Cannabis Suisse go up and down completely randomly.

Pair Corralation between Nu Med and Cannabis Suisse

Given the investment horizon of 90 days Nu Med is expected to generate 22.2 times less return on investment than Cannabis Suisse. But when comparing it to its historical volatility, Nu Med Plus is 5.01 times less risky than Cannabis Suisse. It trades about 0.03 of its potential returns per unit of risk. Cannabis Suisse Corp is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1.69  in Cannabis Suisse Corp on May 13, 2025 and sell it today you would lose (0.20) from holding Cannabis Suisse Corp or give up 11.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Nu Med Plus  vs.  Cannabis Suisse Corp

Nu Med Plus

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Nu Med Plus are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Nu Med exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cannabis Suisse Corp

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nu Med and Cannabis Suisse

The main advantage of trading using opposite Nu Med and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nu Med position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.

The idea behind Nu Med Plus and Cannabis Suisse Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.